These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 24830873

  • 1. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S, Lyngbaek S, Hansen TW, Eugen-Olsen J, Fenger M, Rossing P, Jeppesen JL.
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [Abstract] [Full Text] [Related]

  • 2. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
    Sherif EM, El Maksood AAA, Youssef OI, Salah El-Din NY, Khater OKM.
    J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
    [Abstract] [Full Text] [Related]

  • 3. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S, Hansen TW, Goetze JP, Rossing P.
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [Abstract] [Full Text] [Related]

  • 4. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [Abstract] [Full Text] [Related]

  • 5. Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.
    Theilade S, Lajer M, Hansen TW, Rossing P.
    Acta Diabetol; 2014 Dec; 51(6):973-80. PubMed ID: 25274394
    [Abstract] [Full Text] [Related]

  • 6. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
    Kostopoulou E, Kalavrizioti D, Davoulou P, Sinopidis X, Papachristou E, Goumenos DS, Dimitriou G, Spiliotis BE, Papasotiriou M.
    Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612
    [Abstract] [Full Text] [Related]

  • 7. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S, Hansen TW, Rossing P.
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [Abstract] [Full Text] [Related]

  • 8. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
    Sehestedt T, Lyngbæk S, Eugen-Olsen J, Jeppesen J, Andersen O, Hansen TW, Linneberg A, Jørgensen T, Haugaard SB, Olsen MH.
    Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
    [Abstract] [Full Text] [Related]

  • 9. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1265-1273. PubMed ID: 28495863
    [Abstract] [Full Text] [Related]

  • 10. CRP and suPAR are differently related to anthropometry and subclinical organ damage.
    Lyngbæk S, Sehestedt T, Marott JL, Hansen TW, Olsen MH, Andersen O, Linneberg A, Madsbad S, Haugaard SB, Eugen-Olsen J, Jeppesen J.
    Int J Cardiol; 2013 Aug 10; 167(3):781-5. PubMed ID: 22459389
    [Abstract] [Full Text] [Related]

  • 11. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.
    Diabetes Care; 2009 Feb 10; 32(2):323-8. PubMed ID: 18957531
    [Abstract] [Full Text] [Related]

  • 12. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
    Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen J, Pielak T, Møller LN, Jeppesen J, Lyngbaek S, Fenger M, Olsen MH, Hildebrandt PR, Borch-Johnsen K, Jørgensen T, Haugaard SB.
    J Intern Med; 2010 Sep 10; 268(3):296-308. PubMed ID: 20561148
    [Abstract] [Full Text] [Related]

  • 13. suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease.
    Theilade S, Rossing P, Eugen-Olsen J, Jensen JS, Jensen MT.
    Eur J Endocrinol; 2016 Jun 10; 174(6):745-53. PubMed ID: 26951602
    [Abstract] [Full Text] [Related]

  • 14. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G, Corban MT, Hung OY, Eshtehardi P, Eapen DJ, Al-Kassem H, Rasoul-Arzrumly E, Gogas BD, McDaniel MC, Pielak T, Thorball CW, Sperling L, Quyyumi AA, Samady H.
    Atherosclerosis; 2015 Mar 10; 239(1):55-60. PubMed ID: 25574858
    [Abstract] [Full Text] [Related]

  • 15. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
    Zhou Y, Ren J, Li P, Ma R, Zhou M, Zhang N, Kong X, Hu Z, Xiao X.
    Arch Med Res; 2019 Jul 10; 50(5):249-256. PubMed ID: 31593848
    [Abstract] [Full Text] [Related]

  • 16. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov 10; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 17. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
    Rautio A, Boman K, Eriksson JW, Svensson MK.
    Diab Vasc Dis Res; 2016 May 10; 13(3):183-91. PubMed ID: 26818227
    [Abstract] [Full Text] [Related]

  • 18. Urinary albumin excretion rate is independently related to autonomic neuropathy in type 2 diabetes mellitus.
    Wirta OR, Pasternack AI, Mustonen JT, Laippala PJ, Reinikainen PM.
    J Intern Med; 1999 Apr 10; 245(4):329-35. PubMed ID: 10356594
    [Abstract] [Full Text] [Related]

  • 19. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
    Pawlak K, Buraczewska-Buczko A, Mysliwiec M, Pawlak D.
    Am J Med Sci; 2010 Jan 10; 339(1):5-9. PubMed ID: 19926968
    [Abstract] [Full Text] [Related]

  • 20. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH, Elhenawy YI, Nawar MM.
    J Diabetes Complications; 2015 Jan 10; 29(4):563-7. PubMed ID: 25744546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.